Colloque

Revisited Chemotherapy

    Voir aussi :
    Cellule cancéreuse, vue d’artiste générée avec une I.A.

    Documents et médias

    Programme

    Introduction
    Hugues de Thé

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    New Approaches to Cancer Therapy
    Rene Bernards

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application
    Yves Pommier

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities
    Sophie Postel-Vinay

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Killing Cancer by DNA Damage Through Synthetic Lethality
    Thomas Helleday

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Metabolic Bases of Responses to Chemotherapy in Leukemia
    Jean-Emmanuel Sarry

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies
    Guillaume Bossis

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Microbially Derived Adjuvants for Cancer Chemotherapy
    Filipe Cabreiro

    -
    Non enregistré
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Revisiting Chemotherapy Failure—From a Senescence Point-of-view
    Clemens Schmitt

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Conclusions
    Hugues de Thé

    -
    Colloque
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Voir aussi

    Hugues de Thé, chaire Oncologie cellulaire et moléculaire